Epstein File EFTA00651159: Targeted (DS9)

Epstein Index›Documents›EFTA00651159

💨IMPACT LEVEL 1 — MEH

Epstein File EFTA00651159: Targeted (DS9)

General DocumentDate unavailableEFTA006511591 keyword hits

0

views

0

shares

0

reactions

0

persons

1

keywords

3

excerpts

This document describes Foundation Medicine's targeted sequencing assays for cancer treatment, including genomic profiling and next-generation sequencing technology. The material discusses matching patients with targeted therapies and clinical trials based on genomic profiles. The document appears to be medical or pharmaceutical literature with no apparent connection to the Epstein case.

👤 Named in This Document

No named persons linked yet

🔑 Evidence Keywords

targeted

📋 Key Excerpts3

PersonKeyword

Excerpt 1

informative genomic profile that complement traditional cancer treatment decision tools and often expands treatment options by matching each patient with **targeted**

Excerpt 2

EFTA00651159 Foundation Medicine has developed the first commercially available **targeted** sequencing assays using comprehensive, clinical next-generation

Excerpt 3

Genomic profile results are reported to the oncologist and matched with **targeted** therapies and clinical trials that may be relevant to each individual